期刊文献+

ICU与非ICU病房鲍曼不动杆菌临床分布及耐药性分析 被引量:3

Clinical distribution and drug resistance of Acinetobacter baumannii from ICU and non-ICU wards
下载PDF
导出
摘要 目的统计分析大连医科大学附属第一医院鲍曼不动杆菌的临床分布及对常用抗菌药物的耐药性,并比较ICU病房与非ICU病房分离的鲍曼不动杆菌的耐药率差异。方法 2013年1月至2014年3月共分离鲍曼不动杆菌801株,其中ICU病房519株,占64.79%;非ICU病房282株,占35.21%。标本主要来源于痰液、尿液、血液、胸腹水、脑脊液、伤口分泌物等。利用全自动细菌鉴定及药敏分析仪进行细菌鉴定及药敏测定,补充药敏试验采用K-B纸片扩散法。采用WHONET软件对鲍曼不动杆菌分布及耐药性进行分析。结果 801株鲍曼不动杆菌对15种所测抗生素均具有较高耐药性,其中对米诺环素耐药率略低,为31.5%。ICU病房来源鲍曼不动杆菌对每种抗生素的耐药率均显著高于非ICU病房,差异具有非常显著性意义。结论 ICU病房来源的鲍曼不动杆菌耐药率显著高于非ICU病房分离株,加强鲍曼不动杆菌的控制与监测,临床医师更应结合药敏试验结果合理使用抗菌药物以降低鲍曼不动杆菌的耐药率。 Objective To analyze clinical distribution and antibiotic resistance of Acinetobacter baumannii in our hospital, and to compare resistance rates of A. baumannii isolated from ICU and non - ICU wards. Methods A total of 801 samples were A. baumannii positive from Jan 2013 to Mar 2014, 519 (64.79%) samples were from ICU, while 282 (35.21%) were from non - ICU wards. The clinical specimens mainly included sputum, urine, blood, Pleura1 and peritoneal effusions, cerebrospinal fluid, wound secretion and so on. Bacterial identification and antibiotics susceptibility test were performed by automated bacterial identification and susceptibility analyzers. And complementary drug susceptibility test was performed by K - B disc diffusion method. WHONET software was used to analyze clinical distribution and antibiotic resistance of A. baumannii. Results A. banmannii in all of 801 samples kept higher resistance to 15 antibiotics. The drug re- sistance rate to minoeycline was relatively low (31.5%), The resistance rate to each antibiotic of A. baumannii isolated from ICU was significantly higher than those isolated from non - ICU wards. Conclusion We should pay more attention to monitor the infection of A. baumannii and control the increasing drug resistance rate.
出处 《大连医科大学学报》 CAS 2015年第4期385-387,共3页 Journal of Dalian Medical University
关键词 鲍曼不动杆菌 耐药性 医院感染 Acinetobacter baumannii drug resistance nosocomial infection
  • 相关文献

参考文献2

二级参考文献12

  • 1Gu,B. Tong, M. Q. Zhao, W. J. Liu, G. Y. Ning, M. Z. Pan, S. Y. Zhao, W..Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumanhii isolates from patients in Nanjing, China[J].南京医科大学学报(自然科学版),2007,27(4):316-316. 被引量:32
  • 2Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 3Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 4Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 5Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 6Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
  • 7Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
  • 8Wang H.Guo P,Sun HL,et al.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinerobacter spp from Chinese hospitals[J].Antimicrob Agents Chemother.2007,51(11):4022-4028.
  • 9沈继录,朱德妹,吴卫红,徐晓刚,王明贵.革兰阴性杆菌碳青霉烯酶产生与细菌耐药性关系的研究[J].中华检验医学杂志,2008,31(4):408-414. 被引量:66
  • 10冯雅君,沈萍,杜小幸,俞云松,李兰娟.产碳青霉烯酶KPC-2肺炎克雷伯菌局部流行[J].浙江医学,2008,30(9):923-925. 被引量:61

共引文献703

同被引文献25

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部